ATE336993T1 - Pharmazeutische kombination mit (s)-2-ethoxy-3-4- (2-4-methansulfonyloxyphenylethoxy) phenyl propansäure oder 3-4-2-(4-tert.- butoxycarbonylaminophenyl) ethoxyphenyl-(s)-2- ethoxypropansäure und einem biguanid-arzneimittel - Google Patents

Pharmazeutische kombination mit (s)-2-ethoxy-3-4- (2-4-methansulfonyloxyphenylethoxy) phenyl propansäure oder 3-4-2-(4-tert.- butoxycarbonylaminophenyl) ethoxyphenyl-(s)-2- ethoxypropansäure und einem biguanid-arzneimittel

Info

Publication number: ATE336993T1
Authority: AT; Austria
Prior art keywords: acid; ethoxy; butoxycarbonylaminophenyl; tert; methansulfonyloxyphenylethoxy
Prior art date: 2001-06-01

Application number

AT02728300T

Other languages

English (en)

Inventor

Peter Oehman

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-01

Filing date

2002-05-30

Publication date

2006-09-15

2002-05-30 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE336993T1 publication Critical patent/ATE336993T1/de

Links

XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 title abstract 2
229940123208 Biguanide Drugs 0.000 title abstract 2
229940079593 drug Drugs 0.000 title abstract 2
239000003814 drug Substances 0.000 title abstract 2
239000002253 acid Substances 0.000 title 2
ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 title 2
-1 ETHOXYPHENYL-(S)-2-ETHOXYPROPANE Chemical compound 0.000 title 1
QNDFBOXBUCDYNZ-NRFANRHFSA-N (2s)-2-ethoxy-3-[4-[2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]phenyl]ethoxy]phenyl]propanoic acid Chemical compound C1=CC(C[C@H](OCC)C(O)=O)=CC=C1OCCC1=CC=C(NC(=O)OC(C)(C)C)C=C1 QNDFBOXBUCDYNZ-NRFANRHFSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
CXGTZJYQWSUFET-IBGZPJMESA-N tesaglitazar Chemical compound C1=CC(C[C@H](OCC)C(O)=O)=CC=C1OCCC1=CC=C(OS(C)(=O)=O)C=C1 CXGTZJYQWSUFET-IBGZPJMESA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicinal Preparation (AREA)

AT02728300T 2001-06-01 2002-05-30 Pharmazeutische kombination mit (s)-2-ethoxy-3-4- (2-4-methansulfonyloxyphenylethoxy) phenyl propansäure oder 3-4-2-(4-tert.- butoxycarbonylaminophenyl) ethoxyphenyl-(s)-2- ethoxypropansäure und einem biguanid-arzneimittel ATE336993T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0101980A SE0101980D0 (sv)	2001-06-01	2001-06-01	Pharmaceutical combination

Publications (1)

Publication Number	Publication Date
ATE336993T1 true ATE336993T1 (de)	2006-09-15

Family

ID=20284362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02728300T ATE336993T1 (de)	2001-06-01	2002-05-30	Pharmazeutische kombination mit (s)-2-ethoxy-3-4- (2-4-methansulfonyloxyphenylethoxy) phenyl propansäure oder 3-4-2-(4-tert.- butoxycarbonylaminophenyl) ethoxyphenyl-(s)-2- ethoxypropansäure und einem biguanid-arzneimittel

Country Status (24)

Country	Link
US (1)	US20040152771A1 (de)
EP (2)	EP1666034A1 (de)
JP (1)	JP2004532864A (de)
KR (1)	KR20040008202A (de)
CN (1)	CN1535144A (de)
AT (1)	ATE336993T1 (de)
BR (1)	BR0210128A (de)
CA (1)	CA2448643A1 (de)
CO (1)	CO5540375A2 (de)
CZ (1)	CZ20033234A3 (de)
DE (1)	DE60214185T2 (de)
EE (1)	EE200300584A (de)
ES (1)	ES2269686T3 (de)
HU (1)	HUP0400946A3 (de)
IL (1)	IL159033A0 (de)
IS (1)	IS7058A (de)
MX (1)	MXPA03011005A (de)
NO (1)	NO20035237D0 (de)
PL (1)	PL367891A1 (de)
RU (1)	RU2003136154A (de)
SE (1)	SE0101980D0 (de)
SK (1)	SK14702003A3 (de)
WO (1)	WO2002096402A1 (de)
ZA (1)	ZA200309264B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201513857A (zh) *	2013-07-05	2015-04-16	Cadila Healthcare Ltd	協同性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5783556A (en) *	1996-08-13	1998-07-21	Genentech, Inc.	Formulated insulin-containing composition
US6552055B2 (en) *	1996-12-11	2003-04-22	Dana-Farber Cancer Institute	Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) *	1997-02-19	2000-01-04	Warner-Lambert Company	Combinations for diabetes
SE9801992D0 (sv) *	1998-06-04	1998-06-04	Astra Ab	New 3-aryl-2-hydroxypropionic acid derivative I
SE9801990D0 (sv) *	1998-06-04	1998-06-04	Astra Ab	New 3-aryl propionic acid derivatives and analogs
ATE266409T1 (de) *	2000-04-13	2004-05-15	Pfizer Prod Inc	Synergistische wirkung von glyburide und milrinone

2001
- 2001-06-01 SE SE0101980A patent/SE0101980D0/xx unknown
2002
- 2002-05-30 ES ES02728300T patent/ES2269686T3/es not_active Expired - Lifetime
- 2002-05-30 DE DE60214185T patent/DE60214185T2/de not_active Expired - Fee Related
- 2002-05-30 SK SK1470-2003A patent/SK14702003A3/sk not_active Application Discontinuation
- 2002-05-30 JP JP2002592913A patent/JP2004532864A/ja not_active Withdrawn
- 2002-05-30 BR BR0210128-9A patent/BR0210128A/pt not_active IP Right Cessation
- 2002-05-30 US US10/478,798 patent/US20040152771A1/en not_active Abandoned
- 2002-05-30 EP EP06000170A patent/EP1666034A1/de not_active Withdrawn
- 2002-05-30 KR KR10-2003-7015601A patent/KR20040008202A/ko not_active Withdrawn
- 2002-05-30 PL PL02367891A patent/PL367891A1/xx not_active Application Discontinuation
- 2002-05-30 AT AT02728300T patent/ATE336993T1/de not_active IP Right Cessation
- 2002-05-30 RU RU2003136154/15A patent/RU2003136154A/ru not_active Application Discontinuation
- 2002-05-30 MX MXPA03011005A patent/MXPA03011005A/es unknown
- 2002-05-30 CZ CZ20033234A patent/CZ20033234A3/cs unknown
- 2002-05-30 IL IL15903302A patent/IL159033A0/xx unknown
- 2002-05-30 EP EP02728300A patent/EP1404309B1/de not_active Expired - Lifetime
- 2002-05-30 HU HU0400946A patent/HUP0400946A3/hu unknown
- 2002-05-30 CN CNA028149394A patent/CN1535144A/zh active Pending
- 2002-05-30 WO PCT/SE2002/001038 patent/WO2002096402A1/en not_active Ceased
- 2002-05-30 EE EEP200300584A patent/EE200300584A/xx unknown
- 2002-05-30 CA CA002448643A patent/CA2448643A1/en not_active Abandoned
2003
- 2003-11-25 NO NO20035237A patent/NO20035237D0/no not_active Application Discontinuation
- 2003-11-27 ZA ZA200309264A patent/ZA200309264B/en unknown
- 2003-11-28 IS IS7058A patent/IS7058A/is unknown
- 2003-12-23 CO CO03112108A patent/CO5540375A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2002096402A1 (en)	2002-12-05
CO5540375A2 (es)	2005-07-29
DE60214185T2 (de)	2007-07-19
ES2269686T3 (es)	2007-04-01
MXPA03011005A (es)	2004-02-27
BR0210128A (pt)	2004-06-08
NO20035237D0 (no)	2003-11-25
CZ20033234A3 (cs)	2004-12-15
CN1535144A (zh)	2004-10-06
IL159033A0 (en)	2004-05-12
CA2448643A1 (en)	2002-12-05
PL367891A1 (en)	2005-03-07
DE60214185D1 (en)	2006-10-05
HUP0400946A2 (hu)	2004-08-30
EP1666034A1 (de)	2006-06-07
HUP0400946A3 (en)	2007-11-28
SK14702003A3 (sk)	2004-09-08
EE200300584A (et)	2004-02-16
IS7058A (is)	2003-11-28
SE0101980D0 (sv)	2001-06-01
EP1404309A1 (de)	2004-04-07
JP2004532864A (ja)	2004-10-28
HK1062813A1 (en)	2004-11-26
KR20040008202A (ko)	2004-01-28
RU2003136154A (ru)	2005-02-10
US20040152771A1 (en)	2004-08-05
EP1404309B1 (de)	2006-08-23
ZA200309264B (en)	2005-02-28

Similar Documents

Publication	Publication Date	Title
BR9910913A (pt)	2001-03-06	Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com resistência a insulina
US8480045B2 (en)	2013-07-09	Slotted suction cup with transverse bore and holding device
HRP20090229T1 (en)	2009-05-31	Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and a biphosphonate
JP2007502806A5 (de)	2007-07-12
DK0935961T3 (da)	2008-07-28	Salte af (R)-2-(3-Benzoylphenyl)propionsyre og farmaceutiske præparater indeholdende disse
CY1109472T1 (el)	2012-05-23	Χρηση της 1-4(5-κυανοϊνδολ-3-υλο)βουτυλο-4-(2-καρβαμοϋλοβενζοφουραν-5-υλο)πιπεραζινης και των φυσιολογικα αποδεκτων αλατων αυτης
CY1106328T1 (el)	2011-10-12	Συνθεση glyburide
DE602004023858D1 (de)	2009-12-10	Pharmazeutische zusammensetzung mit einer kombination aus metformin und einem statin
EP1602971A4 (de)	2007-10-31	Lichtquelle und projektor damit
ATE552838T1 (de)	2012-04-15	Wässrige lösung mit aminoglykosid-antibiotikum und bromfenac
DE50213084D1 (de)	2009-01-15	Kosmetische und/oder pharmazeutische zubereitungen
DE60214185D1 (en)	2006-10-05	Pharmazeutische kombination mit (s)-2-ethoxy-3-4-(2-4-methansulfonyloxyphenylethoxy) phenyl propansäure oder 3-4-2-(4-tert.-butoxycarbonylaminophenyl) ethoxyphenyl-(s)-2-ethoxypropansäure und einem biguanid-arzneimittel
EP1784353A4 (de)	2012-03-07	Stoppen des schräglaufs eines behälters
SE0101981D0 (sv)	2001-06-01	Pharmaceutical combination
SE0101982D0 (sv)	2001-06-01	Pharmaceutical combination
AR044826A1 (es)	2005-10-05	Sales derivadas del acido propionico,y su uso medicinal
DE60328787D1 (de)	2009-09-24	Pharmazeutische salze von reboxetin
ATE373462T1 (de)	2007-10-15	Kosmetische zusammensetzung
ATE375154T1 (de)	2007-10-15	Pharmazeutische verwendung von cox-2-hemmern in angiogenese-vermittelten augenerkrankungen
UY28367A1 (es)	2005-01-31	Agentes terapéuticos
DE60310896D1 (de)	2007-02-15	PHARMAZEUTISCHE ZUBEREITUNGEN ENTHALTEND NANOPARTIKEL VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANSULPHONYL-PHENYL)-PYRAZOLOi1,5-BöPYRIDAZIN
PT1353906E (pt)	2004-11-30	Processo para a preparacao de (3-ciano-1h-indolo-7-il) (4-(4-fluorofenetil)piperazina-1-il)metanona e respectivos sais
AR051998A1 (es)	2007-02-21	Agentes terapeuticos
AR045279A1 (es)	2005-10-19	Trans-1-(6-cloro-3-fenilindan-1-il)-3,3-dimetilpiperazina
HK1087690A (en)	2006-10-20	Amine salts of (-)-2-{'2-(4-hydroxyphenyl) ethyl!-thio}-3-'4-(2-{4-'(methylsulfonyl)oxy!phenoxy}ethyl)phenyl! propanoic acid and their use in medicine

Legal Events

Date	Code	Title	Description
2007-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties